Greenlight Capital Q3 2025 Letter

Greenlight Capital funds returned -3.6% in Q3 2025, net of fees and expenses, compared to 8.1% for the S&P 500 index, ...
Blockonomi

Zero Knowledge Proof Whitelist Coming Soon: Solving Blockchain’s Scalability Bottleneck

Ethereum’s gas wars proved that scaling blockchain securely is hard. As the Top Crypto Presale nears, Zero Knowledge Proof ...
Scientific Research Publishing

Estimating Average and Heterogeneous Effects of Special Education: A Causal Machine Learning Perspective ()

Causal Machine Learning (CML) unites ML techniques with CI in order to take advantage of both approaches’ strengths. CML ...
pharmaphorum

Company Profile: Recursion

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Medical Properties Trust: Recent Asset Sales Prove The Shorts Are Wrong

Discover why Medical Properties Trust (MPW) may be undervalued and poised for rebound after asset sales and improved ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...